On June 12, 2024, the US Meals and Drug Administration (FDA) granted full approval to the focused remedy selpercatinib (Retevmo®) for treating grownup and...
THURSDAY, July 11, 2024 (HealthDay Information) — For males present process locoregional staging of prostate most cancers, fluorine-18 prostate-specific membrane antigen-1007 positron emission...